15232-1-AP

antibody from Proteintech Group

Targeting: LOXL2 LOR, WS9-14

ELISA (Data presented on provider website)

Antibody Data

Product number

15232-1-AP

Provider

Proteintech Group

Product name

LOXL2 antibody

Antibody type

Polyclonal

Description

LOXL2 antibody (Cat. #15232-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: ELISA.

Reactivity

Human, Mouse, Rat

Host

Rabbit

Conjugate

Unconjugated

Isotype

IgG

Vial size

20ul, 150ul

References

Submitted references

Catestatin peptide impedes melanoma progression and drug resistance by reprogramming oncogenic signaling pathways.

Mahata S, Kal S, Jati S, Tang K, Webster N, Corti A
Research square 2026 Jan 19;

---

Artificial intelligence accelerates the identification of nature-derived potent LOXL2 inhibitors.

Jia X, Liu M, Tang Y, Meng J, Fang R, Wang X, Li C
Scientific reports 2025 Mar 27;15(1):10540

---

Escin Ia ameliorates DSS-induced chronic colitis in mice by inhibiting inflammation and oxidative stress via the LOXL2/MMP-9 pathway.

Yan J, Xu X, Zhu Y, Wang Y, Duan X
Journal of ethnopharmacology 2025 Apr 9;345:119623

---

Chromosomal 3q amplicon encodes essential regulators of secretory vesicles that drive secretory addiction in cancer.

Tan X, Wang S, Xiao GY, Wu C, Liu X, Zhou B, Jiang Y, Duose DY, Xi Y, Wang J, Gupta K, Pataer A, Roth JA, Kim MP, Chen F, Creighton CJ, Russell WK, Kurie JM
The Journal of clinical investigation 2024 Apr 25;134(12)

---

Dihydroartemisinin Potentiates VEGFR-TKIs Antitumorigenic Effect on Osteosarcoma by Regulating Loxl2/VEGFA Expression and Lipid Metabolism Pathway.

Ding X, Zhang Y, Liang J, Li Q, Hu H, Zhou Y, Zhang B
Journal of Cancer 2023;14(5):809-820